{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:46:00Z","timestamp":1791895560618,"version":"4.3.4"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1995,3]]},"DOI":"10.1212\/wnl.45.3.585","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:14:59Z","timestamp":1336914899000},"page":"585-587","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":82,"title":["Practice Parameter"],"prefix":"10.1212","volume":"45","author":[{"name":"Report of the Quality Standards Subcommittee of the American Academy of Neurology.","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.45.3.585","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T15:59:33Z","timestamp":1711641573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.45.3.585"}},"subtitle":["Appropriate Use of Ergotamine Tartrate and Dihydroergotamine in the Treatment of Migraine and Status Migrainosus (Summary Statement)."],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,3]]}},"alternative-id":["10.1212\/WNL.45.3.585"],"URL":"https:\/\/doi.org\/10.1212\/wnl.45.3.585","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,3]]}}}